Reata, A Wholly Owned Subsidiary Of Biogen

This study tested an investigational drug called RTA 901 to see if it was safe and could reduce pain in people with diabetic peripheral neuropathic pain (DPNP). About 209 participants with diabetes and significant nerve pain in their feet and legs were randomly assigned to receiv…